g.pemberton_uk
TL3 Regional · UK · York, UK
Keeps the UK access pages current — MHRA positions, NHS pathways, and what a private prescription actually involves.
Joined 18 September 2024 · last posted 5d · groups: wiki-editors, regional-uk
137 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #86 · Outcomes › Progress reports · 22 Jul 2026 · 4 likes Picking up post #83: that is the part I would want checked first. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #63 · Compounds › Repair & healing peptides · 20 Jul 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Packaging that arrived damaged: documenting it properly Replied, post #41 · Sourcing › Logistics · 12 Jul 2026 · 3 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #31 · Compounds › Retatrutide · 12 Jul 2026 · 11 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Journal club: what we got wrong in an earlier session Replied, post #73 · Evidence › Journal club · 11 Jul 2026 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
How to ask a question when you cannot say why you are asking it Replied, post #36 · Start Here › How to Ask · 10 Jul 2026 · 0 likes Picking up post #33: that is the part I would want checked first. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
-
Alcohol: what is documented and what is folklore Replied, post #99 · Practice › Interactions · 8 Jul 2026 · 6 likes I read post #97 twice before replying, because I had assumed the opposite. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #12 · Start Here › How to Ask · 1 Jul 2026 · 5 likes Picking up post #9: that is the part I would want checked first. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #55 · Evidence › Journal club · 1 Jul 2026 · 31 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Revisiting: The best-written scientific paper you have read Replied, post #56 · Lounge › Off topic · 27 Jun 2026 · 15 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Constipation management, with a dietitian's contribution Replied, post #84 · Practice › Side effects · 26 Jun 2026 · 0 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
What published stability data actually covers, and what it does not Replied, post #6 · Practice › Storage & stability · 14 Jun 2026 · 2 likes I read post #4 twice before replying, because I had assumed the opposite. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #104 · Practice › Reconstitution · 12 Jun 2026 · 0 likes Picking up post #101: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Revisiting: The best-written scientific paper you have read Replied, post #23 · Lounge › Off topic · 9 Jun 2026 · 5 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Pages past their review date, listed — does this still hold? Started this topic · Meta › Wiki maintenance · 1 Jun 2026 · 12 likes Asking directly, because I could not find a straight answer: Pages past their review date, listed — does this still hold? Nominating something for promotion into the…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #43 · Practice › Storage & stability · 1 Jun 2026 · 15 likes Worth separating two things that post #39 runs together. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #16 · Compounds › Secretagogues & GH axis · 29 May 2026 · 0 likes post #15 is right about the mechanism and I think understates the practical bit. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #60 · Practice › Reconstitution · 27 May 2026 · 3 likes Worth separating two things that post #56 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Transporting a vial for a weekend away — a second dataset Replied, post #64 · Practice › Storage & stability · 26 May 2026 · 7 likes Picking up post #61: that is the part I would want checked first. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #81 · Sourcing › Logistics · 26 May 2026 · 16 likes Coming back to post #79, because the follow-up matters more than the original answer. Import restrictions by jurisdiction: what is legal to import for personal use…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #22 · Analytics › Home & field testing · 18 May 2026 · 0 likes This follows post #19 rather than contradicting it. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids.…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #9 · Practice › Side effects · 10 May 2026 · 11 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #55 · Practice › Administration · 7 May 2026 · 23 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #115 · Practice › Reconstitution · 28 Apr 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #12 · Practice › Dosing & titration · 22 Apr 2026 · 23 likes On post #8 — agreed on the reasoning, with one qualification. When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #24 · Practice › Reconstitution · 19 Apr 2026 · 4 likes This follows post #21 rather than contradicting it. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #15 · Practice › Reconstitution · 18 Apr 2026 · 0 likes post #14 is right about the mechanism and I think understates the practical bit. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #102 · Practice › Reconstitution · 17 Apr 2026 · 11 likes Coming back to post #100, because the follow-up matters more than the original answer. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL…
-
List price versus negotiated price versus what you pay Replied, post #112 · Access › Pricing · 17 Apr 2026 · 32 likes Worth separating two things that post #108 runs together. Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen…
-
List price versus negotiated price versus what you pay Replied, post #96 · Access › Pricing · 16 Apr 2026 · 0 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #62 · Start Here › Welcome · 5 Apr 2026 · 4 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #5 · Practice › Storage & stability · 5 Apr 2026 · 10 likes post #4 answers the question as asked. The question underneath it is different. Published stability data applies specifically to the formulation studied, under the…
-
A 40-week log with the measurement method stated — does this still hold? Replied, post #4 · Outcomes › Progress reports · 24 Mar 2026 · 10 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Grapefruit: why this class is not the class that cares Replied, post #72 · Practice › Interactions · 23 Mar 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #8 · Practice › Dosing & titration · 22 Mar 2026 · 20 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #71 · Practice › Reconstitution · 21 Mar 2026 · 29 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #38 · Lounge › Introductions · 11 Mar 2026 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #20 · Compounds › Repair & healing peptides · 10 Mar 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 26 Feb 2026 · 29 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #67 · Start Here › How to Ask · 25 Feb 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #7 · Access › Pricing · 22 Feb 2026 · 23 likes post #6 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #46 · Research Methods › N-of-1 designs · 15 Feb 2026 · 32 likes post #45 answers the question as asked. The question underneath it is different. Objective versus subjective measures: subjective measures (how you feel) are vulnerable…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #88 · Access › Pricing · 13 Feb 2026 · 0 likes post #87 answers the question as asked. The question underneath it is different. Compute cost per delivered dose at your dose if you want a number you can act on. That…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #22 · Outcomes › Progress reports · 9 Feb 2026 · 29 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #35 · Sourcing › Logistics · 8 Feb 2026 · 0 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #22 · Research Methods › N-of-1 designs · 18 Jan 2026 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. Sample size in n-of-1: you are the sample. Repeated measurements (weekly…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #44 · Devices › Pens & autoinjectors · 15 Jan 2026 · 0 likes On post #40 — agreed on the reasoning, with one qualification. Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track…
-
Waist circumference technique and its repeatability Replied, post #37 · Outcomes › Progress reports · 11 Jan 2026 · 2 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
-
What to include when your question involves a chromatogram Replied, post #30 · Start Here › How to Ask · 9 Jan 2026 · 4 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #83 · Practice › Interactions · 5 Jan 2026 · 7 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Guidelines revision: what changed and why — one year on Replied, post #54 · Meta › Announcements · 4 Jan 2026 · 4 likes This follows post #51 rather than contradicting it. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #29 · Sourcing › Red flags · 28 Dec 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #8 · Practice › Reconstitution · 13 Dec 2025 · 17 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #8 · Compounds › Oral incretins · 12 Dec 2025 · 1 like Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Absence of evidence and evidence of absence Replied, post #8 · Research Methods › Statistics · 7 Dec 2025 · 32 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Pen dose counters: what a click does and does not guarantee Replied, post #31 · Devices › Pens & autoinjectors · 14 Nov 2025 · 6 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
-
Thyroid function tests during substantial weight change Replied, post #116 · Clinical › Bloodwork · 31 Oct 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
A 40-week log with the measurement method stated Replied, post #4 · Outcomes › Progress reports · 12 Oct 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut…
-
Coverage in the US: a map of the usual obstacles Started this topic · Regional › North America · 9 Oct 2025 · 17 likes Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #14 · Clinical › Bloodwork · 6 Oct 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #43 · Analytics › COA interpretation · 28 Sep 2025 · 1 like Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #46 · Practice › Storage & stability · 20 Sep 2025 · 31 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #16 · Start Here › How to Ask · 19 Sep 2025 · 22 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #7 · Sourcing › Regulatory · 13 Sep 2025 · 3 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #32 · Analytics › COA interpretation · 8 Sep 2025 · 1 like Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #46 · Data & Tools › Datasets · 8 Sep 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #11 · Data & Tools › Datasets · 6 Sep 2025 · 0 likes This follows post #8 rather than contradicting it. Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is…
-
Request: show the solution author in the topic list Replied, post #2 · Meta › Feature requests · 1 Sep 2025 · 7 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site.
-
An emergency department visit, described afterwards Replied, post #61 · Safety › Adverse events · 1 Sep 2025 · 31 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #19 · Practice › Side effects · 27 Aug 2025 · 21 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #43 · Practice › Reconstitution · 17 Aug 2025 · 12 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #67 · Compounds › Secretagogues & GH axis · 15 Aug 2025 · 0 likes On post #63 — agreed on the reasoning, with one qualification. Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #27 · Compounds › Oral incretins · 13 Aug 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #25 · Pharmacology › Receptor biology · 9 Aug 2025 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #4 · Data & Tools › Calculators · 6 Aug 2025 · 3 likes Picking up post #2: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #16 · Compounds › Secretagogues & GH axis · 27 Jul 2025 · 16 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #42 · Practice › Dosing & titration · 17 Jul 2025 · 25 likes I read post #40 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #2 · marked as the solution · Compounds › Semaglutide · 17 Jul 2025 · 14 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #17 · Compounds › Semaglutide · 4 Jul 2025 · 7 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #20 · Compounds › Secretagogues & GH axis · 30 Jun 2025 · 1 like Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #75 · Practice › Storage & stability · 29 Jun 2025 · 19 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #14 · Practice › Reconstitution · 20 Jun 2025 · 23 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #92 · Access › Insurance & coverage · 13 Jun 2025 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #85 · Access › Insurance & coverage · 12 Jun 2025 · 17 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #10 · Analytics › Method validation · 6 Jun 2025 · 4 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2025 · 8 likes On post #5 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Publishing an inconvenient result: a case study Replied, post #27 · Sourcing › Independent verification · 31 May 2025 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #5 · Compounds › Secretagogues & GH axis · 27 May 2025 · 0 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #68 · Compounds › Secretagogues & GH axis · 23 May 2025 · 0 likes On post #64 — agreed on the reasoning, with one qualification. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #69 · Outcomes › Body composition · 20 May 2025 · 6 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Pregnancy as an absolute contraindication Replied, post #81 · Safety › Contraindications · 20 May 2025 · 0 likes On post #77 — agreed on the reasoning, with one qualification. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #40 · Clinical › Comorbidities · 14 May 2025 · 1 like Worth separating two things that post #36 runs together. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #8 · Clinical › Special populations · 13 May 2025 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Follow-up: What other technical communities get right that we do not Replied, post #95 · Lounge › Off topic · 12 May 2025 · 17 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 10 May 2025 · 0 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #27 · Clinical › Comorbidities · 3 May 2025 · 28 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #35 · Data & Tools › Calculators · 26 Apr 2025 · 22 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
Reverting an edit that had no revision note Started this topic · Meta › Wiki maintenance · 20 Apr 2025 · 0 likes Posting this under the heading it deserves: Reverting an edit that had no revision note Everything below is what sits behind that. Nominating something for promotion…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #51 · Practice › Reconstitution · 16 Apr 2025 · 15 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Publishing an inconvenient result: a case study Replied, post #8 · Sourcing › Independent verification · 14 Apr 2025 · 2 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #10 · Practice › Dosing & titration · 12 Apr 2025 · 1 like Coming back to post #8, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #9 · Data & Tools › Calculators · 9 Apr 2025 · 0 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Scheduled maintenance and what will be unavailable Replied, post #97 · Meta › Announcements · 4 Apr 2025 · 24 likes Picking up post #94: that is the part I would want checked first. When announcements are made: major policy changes, technical changes affecting site function, planned…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #95 · Access › International · 12 Mar 2025 · 8 likes Coming back to post #93, because the follow-up matters more than the original answer. Currency and exchange rates: paying in different currencies has different costs…
-
Particulates in a reconstituted solution: identifying the likely source — what changed… Started this topic · Analytics › Impurities & related substances · 5 Mar 2025 · 0 likes Particulates in a reconstituted solution: identifying the likely source — what changed since — setting out what I have, and where I think it stops being reliable.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #15 · Practice › Reconstitution · 11 Feb 2025 · 21 likes I read post #13 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #88 · Evidence › Meta-analyses · 10 Feb 2025 · 14 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #82 · Data & Tools › Calculators · 8 Feb 2025 · 0 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Protein density versus volume when you cannot eat much Replied, post #31 · Nutrition & Training › Protein & intake · 28 Jan 2025 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Fixed versus detachable needles: the trade-offs Replied, post #119 · Devices › Syringes & needles · 17 Jan 2025 · 23 likes This follows post #116 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #17 · Compounds › Oral incretins · 3 Jan 2025 · 12 likes This follows post #14 rather than contradicting it. Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a…
-
Isotonicity and what happens when you get it wrong Replied, post #12 · Pharmacology › Formulation chemistry · 30 Dec 2024 · 3 likes post #11 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Criticising the method without criticising the authors Replied, post #27 · Evidence › Study critique · 27 Dec 2024 · 23 likes I read post #25 twice before replying, because I had assumed the opposite. Publication bias: a single published positive trial is weaker evidence than multiple…
-
What we do not know about retatrutide, listed explicitly Replied, post #34 · Compounds › Retatrutide · 27 Dec 2024 · 13 likes I read post #32 twice before replying, because I had assumed the opposite. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #11 · Analytics › Mass spectrometry · 25 Dec 2024 · 30 likes post #10 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Body image changing more slowly than the body Replied, post #126 · Wellbeing › Mental health · 25 Dec 2024 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #5 · Compounds › Other compounds · 16 Dec 2024 · 16 likes Worth separating two things that the opening post runs together. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite.…
-
Feature request: should a dose-equivalence tool exist at all? Started this topic · Data & Tools › Calculators · 15 Dec 2024 · 43 likes Feature request: should a dose-equivalence tool exist at all? — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the…
-
Revisiting: Moderation log format change Replied, post #64 · Meta › Announcements · 11 Dec 2024 · 23 likes This follows post #61 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Why "any advice?" is the least effective ending for a post Replied, post #95 · Start Here › How to Ask · 1 Dec 2024 · 0 likes This follows post #92 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #131 · Analytics › COA interpretation · 27 Nov 2024 · 2 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #43 · Clinical › Prescriber conversations · 8 Nov 2024 · 0 likes Picking up post #40: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Time to steady state after a dose increase Replied, post #144 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 2 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
A promotion I argued against, and why I lost Started this topic · Documentation › Doc review · 5 Nov 2024 · 5 likes Posting this under the heading it deserves: A promotion I argued against, and why I lost Everything below is what sits behind that. Nominating something for promotion…
-
Time to steady state after a dose increase Replied, post #70 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 5 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #104 · Analytics › COA interpretation · 2 Nov 2024 · 27 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #7 · Clinical › Comorbidities · 8 Oct 2024 · 0 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
How to ask for a dose change without antagonising anyone Replied, post #24 · Clinical › Prescriber conversations · 10 Sep 2024 · 14 likes post #23 is right about the mechanism and I think understates the practical bit. Clarifying indication: if a compound is approved for diabetes but you have obesity…
-
Circumference measurements as a poor man's composition estimate Replied, post #111 · Outcomes › Body composition · 30 Aug 2024 · 0 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Promotion criteria, and the one that stops most nominations Replied, post #47 · Documentation › Doc review · 27 Aug 2024 · 7 likes I read post #45 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here.…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #2 · Clinical › Special populations · 25 Aug 2024 · 20 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Correlation in a self-tracked dataset: what it can support Replied, post #30 · Research Methods › Statistics · 21 Aug 2024 · 2 likes P-values and significance: p
-
Cold packs, phase-change material, and what survives ten days Replied, post #113 · Sourcing › Logistics · 17 Jul 2024 · 0 likes Coming back to post #111, because the follow-up matters more than the original answer. Tracking stops updating: tracking last updated days ago usually means the package…
-
Pen wastage and its effect on real cost Replied, post #2 · Access › Pricing · 16 Jun 2024 · 31 likes the opening post is right about the mechanism and I think understates the practical bit. Biosimilars and future generics: as patents expire, biosimilar and generic…
-
Why I ask for the gradient before I discuss the number Started this topic · Analytics › HPLC & UHPLC · 4 Jun 2024 · 12 likes The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to…
-
Assessing a warm arrival: the decision process — one year on Replied, post #131 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Assessing a warm arrival: the decision process — one year on Replied, post #104 · Sourcing › Logistics · 1 Jun 2024 · 9 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.